POMDOCTOR LIMITED American Depositary Shares (POM) is a publicly traded the market company. As of May 21, 2026, POM trades at $0.12 with a market cap of $14.04M and a P/E ratio of 0.10. POM moved +1.15% today. Year to date, POM is -61.64%; over the trailing twelve months it is flat. Its 52-week range spans $0.06 to $6.43. Rallies surfaces POM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Pomdoctor Limited Reports 16.7% Revenue Growth to RMB399.9M, Net Loss Widens: Pomdoctor Limited's fiscal 2025 net revenues rose 16.7% to RMB399.9 million, driven by a 69.3% surge in Internet hospital sales to RMB150.7 million, while gross profit climbed 9.6% to RMB52.3 million. Net loss widened to RMB130.9 million mainly due to one-time IPO expenses despite a 328.5% R&D investment increase.
| Metric | Value |
|---|---|
| Price | $0.12 |
| Market Cap | $14.04M |
| P/E Ratio | 0.10 |
| EPS | $1.29 |
| Dividend Yield | 0.27% |
| 52-Week High | $6.43 |
| 52-Week Low | $0.06 |
| Volume | 54.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.02B |
| Net Income | $327.00M |
| Gross Margin | 0.00% |
POM analyst coverage data. Average price target: $0.00.